Evidence map›Paper›PMID 41303334›Full record

ArticleInternational journal of molecular sciences2025

New Role of Protein Misfolding Corrector in the ER Stress-Inflammation Axis: Possible Therapeutic Indication in Neuronal and Epithelial Tumor Cells.

Michela Pecoraro, Adele Serra, Maria Julia Lamberti, Maria Pascale, Silvia Franceschelli

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Michela PecoraroDepartment of Pharmacy, University of Salerno, Via Giovanni Paolo II, 84084 Fisciano, Italy.
Adele SerraDepartment of Pharmacy, University of Salerno, Via Giovanni Paolo II, 84084 Fisciano, Italy.
Maria Julia LambertiInstituto de Biotecnología Ambiental y Salud (INBIAS UNRC CONICET)-UNRC, Río Cuarto 5800, Argentina.ORCID 0000-0001-7162-0520
Maria PascaleDepartment of Pharmacy, University of Salerno, Via Giovanni Paolo II, 84084 Fisciano, Italy.
Silvia FranceschelliDepartment of Pharmacy, University of Salerno, Via Giovanni Paolo II, 84084 Fisciano, Italy.ORCID 0000-0001-7412-7918

Funding

University of Salerno ORSA231580
6 · The paper itself

Abstract

Protein misfolding diseases are characterized by structurally abnormal proteins that lose their functionality, resulting in cellular and tissue dysfunction. Neurodegenerative diseases, including Parkinson's disease, Alzheimer's disease and Huntington's disease, share a common etiopathogenesis characterize by the accumulation of misfolded proteins. These proteins autonomously aggregate within neuronal cells, triggering inflammation and cell death. The accumulation of misfolded proteins triggers endoplasmic reticulum (ER) stress, leading to alter Ca

Indexed as

Endoplasmic Reticulum StressInflammationNeuronsA549 CellsCalciumCell Line, TumorEpithelial CellsHumansProtein FoldingProteostasis DeficienciesThapsigarginCalciumThapsigargincorrectorER stressinflammationmisfolding proteinneurodegenerative disease

Identifiers

PMID41303334
PMCPMC12652013

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.